Andrew Porter

Dr. Andrew Porter serves as Research Integrity and Training Adviser at Cancer Research UK Manchester Institute, part of the University of Manchester's medical research ecosystem. He is affiliated with both the Christabel Pankhurst Institute and Manchester Cancer Research Centre, focusing on cell biological mechanisms in cancer development.

His research spans RAC1 signaling pathways, centriole duplication mechanisms, and melanoma invasion processes, with particular expertise in cytoskeletal regulators like Tiam1 and CASK. Recent work examines how ultraviolet light-induced collagen degradation affects tumor microenvironments and how mitotic spindle orientation influences epithelial cancer progression.

Dr. Porter's publication trends show consistent high-impact output in cell biology journals, with his 2021 Nature Communications paper on melanoma accumulating 67 citations. His research integrates molecular pathway analysis with translational cancer models, maintaining strong collaboration with Professor Malliri's research group.

• Research Integrity and Training Adviser role
• Digital research infrastructure development
• Open science advocacy through dataset creation

As Training Adviser, Dr. Porter oversees researcher development programs and ethical compliance frameworks. His 2025 dataset on Digital Notebooks demonstrates commitment to modernizing research practices, while his laboratory work continues to elucidate fundamental mechanisms in cancer cell biology through rigorous experimental design and collaborative science.